Author:
Hour Tzyh-Chyuan,Chung Shiu-Dong,Kang Wang-Yi,Lin Ying-Chu,Chuang Shu-Ju,Huang A-Mei,Wu Wen-Jeng,Huang Shu-Pin,Huang Chao-Yuan,Pu Yeong-Shiau
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Reference55 articles.
1. Altavilla A, Iacovelli R, Procopio G, Alesini D, Risi E, Campenni GM, Palazzo A, Cortesi E (2012) Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant. Cancer Biol Ther 13:1001–1008
2. Attar RM, Takimoto CH, Gottardis MM (2009) Castration-resistant prostate cancer: locking up the molecular escape routes. Clin Cancer Res 15:3251–3255
3. Bakin RE, Gioeli D, Sikes RA, Bissonette EA, Weber MJ (2003) Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells. Cancer Res 63:1981–1989
4. Barton S, Starling N, Swanton C (2010) Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapies. Curr Cancer Drug Targets 10:799–812
5. Beer TM, El-Geneidi M, Eilers KM (2003) Docetaxel (taxotere) in the treatment of prostate cancer. Expert Rev Anticancer Ther 3:261–268
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献